Literature DB >> 7519239

Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

R Rotem-Yehudar1, S Winograd, S Sela, J E Coligan, R Ehrlich.   

Abstract

The expression of class I major histocompatibility complex antigens on the surface of cells transformed by adenovirus 12 (Ad12) is generally very low, and correlates with the high oncogenicity of this virus. In primary embryonal fibroblasts from transgenic mice that express both endogenous H-2 genes and a miniature swine class I gene (PD1), Ad12-mediated transformation results in suppression of cell surface expression of all class I antigens. Although class I mRNA levels of PD1 and H-2Db are similar to those in nonvirally transformed cells, recognition of newly synthesized class I molecules by a panel of monoclonal antibodies is impaired, presumably as a result of inefficient assembly and transport of the class I molecules. Class I expression can be partially induced by culturing cells at 26 degrees C, or by coculture of cells with class I binding peptides at 37 degrees C. Analysis of steady state mRNA levels of the TAP1 and TAP2 transporter genes for Ad12-transformed cell lines revealed that they both are significantly reduced, TAP2 by about 100-fold and TAP1 by 5-10-fold. Reconstitution of PD1 and H-2Db, but not H-2Kb, expression is achieved in an Ad12-transformed cell line by stable transfection with a TAP2, but not a TAP1, expression construct. From these data it may be concluded that suppressed expression of peptide transporter genes, especially TAP2, in Ad12-transformed cells inhibits cell surface expression of class I molecules. The failure to fully reconstitute H-2Db and H-2Kb expression indicates that additional factors are involved in controlling class I gene expression in Ad12-transformed cells. Nevertheless, these results suggest that suppression of peptide transporter genes might be an important mechanism whereby virus-transformed cells escape immune recognition in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519239      PMCID: PMC2191597          DOI: 10.1084/jem.180.2.477

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  62 in total

1.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

Authors:  O Rötzschke; K Falk; K Deres; H Schild; M Norda; J Metzger; G Jung; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

2.  Heavy chain of HLA-A and HLA-B antigens is conformationally labile: a possible role for beta 2-microglobulin.

Authors:  D Lancet; P Parham; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  A cDNA clone containing the entire coding sequence of a mouse H-2Kd histocompatibility antigen.

Authors:  J L Lalanne; C Delarbre; G Gachelin; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

4.  The expression of major histocompatibility antigens under metallothionein gene promoter control.

Authors:  J H Weis; J G Seidman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

5.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.

Authors:  B A White; F C Bancroft
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

6.  Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids.

Authors:  R Bernards; A Houweling; P I Schrier; J L Bos; A J Van der Eb
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

7.  Mouse beta 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs.

Authors:  J R Parnes; B Velan; A Felsenfeld; L Ramanathan; U Ferrini; E Appella; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice.

Authors:  W I Frels; J A Bluestone; R J Hodes; M R Capecchi; D S Singer
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

10.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.

Authors:  P I Schrier; R Bernards; R T Vaessen; A Houweling; A J van der Eb
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

View more
  13 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

Review 3.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens.

Authors:  S C Kring; K R Spindler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture.

Authors:  A Hoos; C D'Incan; L Gissmann; A Altmann; F Momburg; I Nindl; W Osen; B H Schönning; I Jochmus
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Induction of neuronal and tumor-related genes by adenovirus type 12 E1A.

Authors:  Hancheng Guan; Jim F Williams; Robert P Ricciardi
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 7.  Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation.

Authors:  R Ehrlich
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

8.  Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport.

Authors:  R Thäle; U Szepan; H Hengel; G Geginat; P Lucin; U H Koszinowski
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.

Authors:  A B Del Campo; J Carretero; J A Muñoz; S Zinchenko; F Ruiz-Cabello; G González-Aseguinolaza; F Garrido; N Aptsiauri
Journal:  Cancer Gene Ther       Date:  2014-06-27       Impact factor: 5.987

10.  Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A.

Authors:  G J Schouten; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.